46.46.Z - Wholesale trade of pharmaceutical and medical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
46.45.Z - Wholesale trade of perfumes and cosmetics
47.29.Z - Retail trade
47.73.Z - Retail sale of pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
72.19.Z - Scientific research and development activities
82.30.Z - Activities related to organizing fairs, exhibitions, and congresses
2020 | 2021 | 2022 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 3 | 6,3 | 5,2 | -17,4 |
EBITDA | 3,6 | 6,7 | 5,6 | -16,1 |
Short time liabilities | 2,9 | 5,2 | 10,1 | 94,7 |
Equity capital | 6,2 | 9 | 9,2 | 1,9 |
Operating profit (EBIT) | 3,2 | 6,3 | 5,1 | -18,6 |
Assets | 9,2 | 14,2 | 19,3 | 36,1 |
Net profit (loss) | 2,4 | 5,2 | 4,2 | -19,5 |
Cash | 3,5 | 2,6 | 0,5 | -81,1 |
Net income from sale | 21,3 | 32,4 | 38,7 | 19,3 |
Liabilities and provisions for liabilities | 2,9 | 5,2 | 10,1 | 95,3 |
Working assets | 8,3 | 12,5 | 17,9 | 43,2 |
Depreciation | 0,3 | 0,4 | 0,5 | 19,9 |
% | % | % | p.p. | |
Profitability of capital | 38,8 | 57,5 | 45,5 | -12 |
Equity capital to total assets | 68,2 | 63,4 | 47,5 | -15,9 |
Gross profit margin | 13,9 | 19,4 | 13,4 | -6 |
EBITDA Margin | 16,7 | 20,7 | 14,5 | -6,2 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 50 | 58 | 95 | 37 |
Current financial liquidity indicator | 2.8596227169036865 | 2.401215076446533 | 1.7657792568206787 | -0,6 |
Net dept to EBITDA | -0.6037821769714355 | -0.30166059732437134 | -0.05353319272398949 | 0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane